Shares of Iovance Biotherapeutics surged following the announcement of accelerated approval from the U.S. Food and Drug Administration for its groundbreaking metastatic melanoma treatment. Significant Stock Surge With a remarkable 41% increase on Tuesday, Iovance's stock reached $12.86, marking its most substantial growth since June 3, 2016, when it saw a surge of 43%, as … [Read more...] about Iovance Biotherapeutics FDA Approval
biotechnology
Moderna Inc. Sees Stock Rally as Phase 3 Trial Begins
Shares of biotechnology company Moderna Inc. experienced a rare rally on Tuesday, with investors enjoying their first gain in two weeks. This positive movement came after the company announced that the first participant had been dosed in a Phase 3 trial of its combination vaccine candidate against the flu and COVID-19 in the U.S. Adding to the optimistic sentiment, ARK Genomic … [Read more...] about Moderna Inc. Sees Stock Rally as Phase 3 Trial Begins
